Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Gary, T.
Cancer related venous thromboembolism - prophylaxis and therapy.
Vasa. 2014; 43(4):245-251
Doi: 10.1024/0301-1526/a000359
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Gary Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Cancer is a highly thrombophilic entity leading to a high rate of symptomatic and even asymptomatic venous thromboembolic (VTE) events in patients suffering from malignant disease. As VTE events have impact on survival and can be reduced significantly by anticoagulant treatment, guidelines on prophylaxis of these events by means of anticoagulation exist from various societies. Purpose of this review is to give a concise overview of current possibilities for prophylaxis and also for the therapy of VTE events in cancer patients.
- Find related publications in this database (using NLM MeSH Indexing)
- Anticoagulants - adverse effects
- Anticoagulants - therapeutic use
- Antineoplastic Agents - adverse effects
- Blood Coagulation - drug effects
- Heparin, Low-Molecular-Weight - adverse effects
- Heparin, Low-Molecular-Weight - therapeutic use
- Humans -
- Neoplasms - blood
- Neoplasms - complications
- Neoplasms - drug therapy
- Neoplasms - mortality
- Practice Guidelines as Topic -
- Risk Assessment -
- Risk Factors -
- Treatment Outcome -
- Venous Thromboembolism - blood
- Venous Thromboembolism - etiology
- Venous Thromboembolism - mortality
- Venous Thromboembolism - prevention & control
- Find related publications in this database (Keywords)
- Cancer
- venous thromboembolism
- pulmonary embolism
- low molecular weight heparin